Researchers develop a new means of killing harmful bacteria
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
11 MIT affiliates and more than 30 alumni are identified as movers, makers, and game changers in their respective fields.
Three neuroscientists at MIT have been selected to receive awards from the Society for Neuroscience.
In Compton Lecture, NIH director details the importance of reaching out to others.
Time-saving tool takes advantage of CRISPR gene-editing technology.
Sangeeta Bhatia combines clinical and engineering perspectives to tackle complex health challenges.
NIH-sponsored work to characterize genetic variation in human tissues with roles in diabetes, heart disease, and cancer.
Transformative partnership with Ted Stanley will spur researchers to reveal biology of psychiatric disorders.
Alumnus strikes delicate balances in big data — helping define the future of health care.
Chemists devise a new way to manufacture peptide drugs, which hold promise for treating many diseases.
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Work reveals how a genome-editing tool works to correct errors in the genetic code.